

Get in the KNOW
on LA Startups & Tech
XMeet the Startup That Wants To Deliver Ketamine to Your Door
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Ketamine is on the come up in the pharmaceutical world. Once confined to nightclubs and operating rooms, the drug is quickly gaining recognition as a valuable tool for treating mental health disorders including depression and anxiety.
Amid these rising tides, Wondermed has emerged, offering telehealth consultations and, potentially, the ability to deliver the drug right to your doorstep—all while building out a virtual platform and collecting data on how to use the molecule more effectively.
At the moment, the company provides a mail order service for courses of ketamine lozenges to those who’ve been prescribed the drug along with a telehealth software bridge between doctor and patient. Wondermed currently operates in five states — California, Texas, Florida, New York and Connecticut, though it plans to expand to another eight to 10 states in the next two weeks.
In the long run however, its plans are much bigger than being a link between doctors and patients.
“We generate more than 3,000 data points on every patient that comes into the funnel, and actually receives the medication,” says co-founder & Managing Director Jose Aycart.
His company is building out its online platform to collect and analyze patient data and provide mental health support services that may be useful, regardless of whether or not a patient is taking ketamine.
These data show in granular detail how ketamine therapies work. Does the route of administration matter? Does time of day matter? What types of patients are most likely to experience positive outcomes? It’s this data that represents the biggest business opportunity for Wondermed. The specifics of the monetization are still being worked out, but Aycart says it will never sell anonymized patient data to other companies.
Wondermed is in the midst of a seed funding round, targeting $7 million by the end of the month; It’s raised $5.6 million so far.
The company makes a bit of revenue by charging patients for consultations, but in the event that a patient doesn’t wind up using Wondermed’s platform, the consultation fee is refunded. For patients who are prescribed ketamine, the company charges only as much as the drugs cost them ($249 per month, which includes four doses), so neither Wondermed nor the physicians in its employ are incentivized to over-prescribe.
The drugs themselves are supplied by Tailor Made Compounding, a pharmacy in Nicholasville, Kentucky, and Wondermed is working on additional contracts in the pipeline with several other suppliers.
. Wondermed’s transformation comes as ketamine, which has typically been restricted to use as a general anesthetic, is quickly gaining recognition as a valuable tool for treating mental health disorders like depression and anxiety.
“What I’ve found interesting is how rapidly this field has emerged,” says Steven Grant, a drug and addiction researcher who spent 25 years at the National Institute on Drug Abuse and is now retired.
Ketamine is a simple organic molecule that first gained clinical popularity in the 1960s as an anesthetic. It produces a dissociative state in patients and dulls pain. Once in the bloodstream, the molecule travels to the brain where it binds to a protein called NMDA on the surface of neurons. NMDA has a variety of jobs, but it’s best-known for its role in learning, memory, and neuroplasticity—or the brain’s ability to form new pathways between neurons.
While the research into why ketamine is such an effective treatment for depression and anxiety is ongoing, the consensus so far is that the molecule’s power comes from this ability to rewrite or rewire the brain’s circuitry. If you’ve ever had an anxiety attack or a depressive episode, it can often feel like you’re stuck in a mental loop. Ketamine, it seems, offers a way to break that loop.
“It was this idea that you're increasing your neurological connections in the brain,” says Aycart. “You have the opportunity now to spark new forms of thought, new forms of emotion, or even new ideas.”
Unlike selective serotonin reuptake inhibitors (SSRIs) and other traditional drugs used to treat depression, ketamine’s effects are fast-acting—often appearing within minutes or hours of administration—and don’t require taking the drug daily.
“It really is revolutionary, and that’s why now more than ever, people are starting to get access to it, and companies like ourselves are really trying to bring it to people as an alternative form of medicine,” says Aycart.
Grant says the rise of ketamine clinics and telehealth services like Wondermed are likely a net positive because they increase patient access to drugs patients need, but he also has reservations about how the therapies are being applied.
Many of these psychoactive drugs—especially ketamine—are intended to be used in tandem with therapy, or at least under the supervision of a trained professional. Increasing the brain’s plasticity is a valuable tool for breaking out of depressive loops, but unless a professional is there to help the patient settle into a healthier mental pattern, the full benefits may be left on the table.
Wondermed offers a variety of supplementary support and strategies along with the drugs themselves, but taking advantage of these tools is left to the patient’s discretion. Grant would like to see a larger focus on extending and expanding that auxiliary support.
The company says it’s focused on building out the platform’s nonmedicinal mental health strategies—things like breathwork, meditation, music therapy—and adding them to an app. If they can get enough people on board, the eventual plan could be to sell health insights back to patients through a subscription model or something similar. They may even patent their own psychedelic molecules in the future. But all of this is likely quite a ways out.
“What we're trying to do is very new, and the landscape yet hasn't been built out,” says Aycart.
Clarification: This story has been updated to clarify Wondermed's monthly rate for ketamine lozenges.
From Your Site Articles
- Psychedelic Therapies Are Gaining Steam as Attitudes Change - dot ... ›
- Ketamine for Depression Is Now Available by Injection - dot.LA ›
- Ketamine Clinics Are Opening Across Los Angeles - dot.LA ›
- Pasithea Opens a Chic Clinic in Beverly Hills to Administer Ketamine - dot.LA ›
- New Pasithea Ketamine Clinic In Beverly Hills - dot.LA ›
- Pasithea Opens a Ketamine Clinic In Beverly Hills - dot.LA ›
Related Articles Around the Web
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Rain's Latest Funding Fuels the Future of Financial Wellness
09:21 AM | April 11, 2025
🔦 Spotlight
Happy Friday,
This week, the LA tech scene buzzed with news that Rain, a leader in financial wellness, hassecured $75 million in Series B equity funding, spearheaded by Prosus. This isn't just another funding round; it's a pivotal chapter in Rain's mission to transform how American workers interact with their earnings.
Since its inception, Rain has been at the forefront of innovation in financial technology, particularly with its earned wage access solutions. The concept was simple yet revolutionary: allow workers to access their earned wages instantly, mitigating financial stress and dependency on high-interest payday loans. This vision quickly gained traction, propelling Rain from a promising startup to a key player in the fintech space.
What makes this Series B funding particularly noteworthy is what it represents on a larger scale. It's not just an influx of capital but a strong endorsement of Rain's potential to expand even further. With previous rounds fueling their initial growth and strategic partnerships, such as their notablecollaboration with Marqeta to enhance payment technologies, Rain has steadily built a foundation not just for success but for significant impact.
As Rain secures this significant new funding, their initiative to reshape financial wellness is set to expand dramatically, showcasing the profound impact tech can have on everyday financial challenges.
Looking forward to seeing how their innovations will drive change in the financial landscape.
🤝 Venture Deals
LA Companies
- Dosen, a Los Angeles-based HRtech startup founded by Ronan Wall, Victor Burke, and Cian McCarthy, has secured $2.3M in an oversubscribed pre-seed funding round led by Affinity Ventures. The company offers an AI-powered platform that aligns employee-led learning with business goals through personalized, gamified development programs. The funds will be used to scale the platform, enhance AI-driven personalized learning, and improve employee engagement and productivity. - learn more
- Plug, a Santa Monica-based company operating an EV-exclusive wholesale online auction platform, has secured $6.7M in an oversubscribed seed funding round led by Floodgate, Autotech Ventures, and A*. The company has also launched Plug Trade Desk™, the first EV-focused service designed to help dealers confidently price, move, and monetize trade-ins. The newly acquired funds will be used to enhance Plug's technology and expand its services, aiming to support dealers in navigating the growing used EV market. - learn more
- Gallatin AI, a defense tech startup, has raised $15M in seed funding led by 8VC to scale its AI-powered logistics platform, Navigator. The tool helps military logisticians predict, plan, and execute operations more efficiently in contested environments. Funds will be used to expand the team and deploy the platform across military services. - learn more
- BLNG AI, a generative AI platform based in Los Angeles and Paris, raised $3M in seed funding led by Speedinvest to streamline jewelry design by turning sketches into photorealistic renderings and animations. The funding will support commercialization, team expansion in Europe and the U.S., and the launch of a subscription-based app for luxury brands and independent jewelers. - learn more
- Amca, a newly launched aerospace company focused on modernizing the industrial supply chain, has raised $76M in funding from investors including Caffeinated Capital, Founders Fund, Lux Capital, Andreessen Horowitz, and others. The company plans to acquire specialized suppliers and develop new aerospace products, aiming to strengthen and future-proof the sector’s manufacturing and innovation capabilities. - learn more
- Turbine Finance Corp., a Santa Monica, California-based data science-driven liquidity platform, has raised a total of $21.75M in equity funding, comprising a $13M Series A round co-led by Alpha Edison and TTV Capital, and a previously unannounced $8.75M seed round with participation from Fin Capital, B Capital, and Sozo Ventures. Additionally, the company secured up to a $100M warehouse facility from Silicon Valley Bank to provide credit facilities to venture investors. The combined funding of $121.75M will be used to deploy the warehouse line and expand Turbine's data science team. Turbine's platform enables private equity and venture firms to offer limited partners access to the value of their portfolio investments without reducing exposure, leveraging machine learning to expedite underwriting processes. - learn more
- Gente Beauty, an innovative Brazilian body care brand, has received a lead investment from Webster Capital, a private equity firm specializing in consumer and healthcare sectors. This partnership aims to support Gente Beauty's growth and expansion in the beauty industry. - learn more
LA Venture Funds
- Alexandria Investment Partners participated in a $41M Series A round for Solu Therapeutics, a Boston-based biotech company developing targeted protein degradation therapies. The funding will advance its lead candidate, STX-0712, which recently entered a Phase 1 clinical trial for CMML and other advanced blood cancers. - learn more
- Calibrate Ventures participated in SigIQ.ai's $9.5M seed funding round. SigIQ.ai, based in Berkeley, California, is an AI tutoring startup focused on providing personalized education through advanced AI models. The funds will be used to hire top talent, enhance their AI models, and scale their platforms to educational systems worldwide. - learn more
- Rusheen Capital Management participated in Zero Industrial's $10M Series A funding round, aiming to accelerate the development of thermal energy storage solutions in North America. Zero Industrial focuses on deploying large-scale thermal energy storage projects to enhance energy efficiency and support decarbonization efforts. The funding will be used to expand their project pipeline and advance the commercialization of their technology. - learn more
LA Exits
- Bread Beauty Supply has been acquired by Cost of Doing Business (CODB), a holding company founded in 2024 by Topicals founder and CEO Olamide Olowe and president Sochi Mbadugha. The acquisition aims to expand Bread's retail presence in the U.S., starting with an increased footprint in Sephora stores. Founder Maeva Heim will continue as Chief Creative Officer, focusing on the brand's creative direction, while CODB will manage strategic operations. This move reflects CODB's commitment to supporting Black-owned businesses and fostering diversity in the beauty industry. - learn more
Read moreShow less
Part Pixar, Part Roomba: Meet Moxie, the Pasadena-Built Learning Robot for Children
05:53 AM | April 29, 2020
Wide-eyed and sweet, meet Moxie, the $1,500 robot for children.
The creators of the one-foot tall emotive machine want Moxie to become your child's newest companion. Geared toward autistic children, the company believes Moxie embodies "the very best of humanity" in a form of technology that fuels learning.
"What we are trying to do with this product is to amp up the benefit of social or, if you like, emotional intelligence," said its creator Paolo Pirjanian. "I want every child to be able to access this."
Over the last four years, Pirjanian, the former chief technology officer at iRobot, and his team of therapists, designers and engineers at Pasadena-based Embodied built a battery-powered creature that makes eye contact, reads facial expressions and converses with children. Pirjanian eventually hopes to develop these robots for older adults in isolation or those with Alzheimer's or dementia.
The venture-backed company has raised $34 million in the process, securing money from the funds of big name companies looking to bring artificial intelligence into our everyday lives including Amazon, Intel and Toyota.
"What Paolo has built with the team at Embodied is a new way for humans and machines to interact that involves emotional intelligence, emotional awareness and really tries to infuse humanity into a field of machines," said Jason Schoettler an investor and co-founder of Calibrate Ventures. "This is not an evolution in my view, this is a revolutionary step forward."
Moxie Makes eye contact, reads facial expressions and converses with children. Image courtesy of Embodied
The robot looks less like Stars Wars C-3PO than a character out of a Pixar movie with giant green eyes, rosy cheeks and a round head. It's pre-programed lessons are intended to guide children through development with discussions about feelings and relationships- difficult areas for children with autism to navigate.
The U.S. Centers for Disease Control and Prevention estimates that one in 54 U.S. children have autism spectrum disorder, a neurodevelopmental disorder that makes interaction and communication challenging.
Researchers have become increasingly interested in the use of so-called social robots to help children with autism develop social skills.
"The robot actually does personalize its interactions for that particular child over time using machine learning," Pirjanian said. "The data that we are collecting will potentially help the healthcare community to have better insights into what techniques work for what kind of a child, because it has to be individualized for every single child."
But such personal data can become prey for hackers. Pirjanian said there's sufficient protections. The robot's information is encrypted and can only be unlocked by a parent's unique key. It's also audited by Privo for compliance with regulations governing children's online protection.
In a six-week study conducted by Embodied, their researchers found Moxie improved eye contact, self-esteem and emotional regulations for school-aged children with autism after regularly interacting with the robot. But, the company's study is of a small sample size and may not actually reflect real life outcomes.
Moxie the Robot: AI for Autistic Childrenwww.youtube.com
Other companies have sought to jump into the market.
SoftBank Robotics has bankrolled NAO, an educational robot that sells a version aimed at autistic children for about $17,000. RoboKind, a Texas-based robotics company built Milo, a $6,500 robot for autistic children that includes plus a $3,500 subscription fee. Both have versions that are aimed at the wider $3.9 billion educational robotics market that includes bots that teach STEM. But the market has yet to really take hold.
Moxie could change that and it could shake up the $20.4 billion consumer robotics market. The company opened up its site for pre-orders this week and will give customers access to a full-year subscription which includes so-called behavioral analytics and new content that includes "missions," which are often task or challenges that Moxie presents to children.
John Lee, a partner at JAZZ Ventures and investor in the company, said that he found the technology intriguing because it really improved people's lives. Parents with autistic children often struggle with diagnosis and learning how to guide their children toward resources.
"Embodied's mission is to build socially and emotionally intelligent companions that promote positive social skill building in children," he said in an email. "This might open up people's minds to how technology can be used in a positive way and, perhaps, that opens up new products that address other markets."
Maja Mataric is a pioneer in the field of social robotics who was one of Embodied's original co-founders but is no longer associated with the company. Mataric, who holds shares in the company, declined to state why the two parted ways.
But, she said one of the biggest challenges that companies like Embodied face is having the ability to test the robot fully to see if it offers true therapeutic benefits to children.
"Companies usually need to spin out a product in just a couple to three years. That's the startup money that they have. A clinical study altogether will take two to three years just to conduct. So there's no time," she said.
Still, she said robots hold promise. Earlier this year Mataric, the founding director of University of Southern California's Robotics and Autonomous Systems Center was a co-author on a study looking at the ability of robots to improve development for autistic children using the technology at home. In the study, Mataric and her team at USC left Kiwi, a social robot that gauges child interest and tailors response, at the homes of 17 autistic children for a month. The bot played space-themed math games and offered personal feedback. At the end of intervention, all improved math skills while 92% improved social skills.
Researchers have become increasingly interested in the use of so-called social robots to help children with autism develop social skills.Courtesy of Embodied
Still, she said there hasn't been wide scale studies on the use of robotics in the home.
"Robots are not aspirin," she said. "What happens in the worst case scenario? What happens in the best case scenario?"
"Sometimes the best case scenario could be the worst case scenario, right? What if the robot is so effective that the child adores it, but they adore it so much that they don't play with anyone else," she said. "Those are the kinds of things, one has to worry about."
The idea for the company can be traced back to Pirjanin's own experiences. Born in Iran, the Armenian Christian fled to Denmark after the Revolution as a teenager. Feeling lost and behind in his studies, Pirjanin eventually bought a computer and became enthralled with its possibilities after seeing a documentary on Pixar Animation Studios.
"I was fascinated. 'How can a computer this simple create something so lifelike?'" he said to himself. "It drew me into technology. I followed that curiosity."
He got a PhD there and moved to California to help develop robots for exploration on Mars at NASA's Jet Propulsion Laboratory. From there, he went on to work with Idealab founder Bill Gross where he eventually helped develop a visual navigation technology that was the foundation of his company Evolution Robotics.
That company was bought in 2012 by iRobot, maker of the self-driven Roomba vacuum, for $74 million and he became the company's chief technology officer. iRobot, which last year recorded selling its 30 millionth robot, is arguably one of the few companies that has successfully mass marketed robots, a useful background for somebody attempting to convince parents that their children need robots to develop emotional skills.
Pirjanian said he left the company because he felt he hadn't been doing the work that had originally sparked his imagination. Embodied, he said, was a way to bring all the skills he had learned as a roboticist from machine learning to natural language processing to life. At first he eyed building a robot for the elderly, but learned about the benefits it was having on children.
Children who have social emotional and cognitive challenges were seeing benefits from a robot companion that improved their chances in society, he said.
"I knew very well this was a complete moonshot," Pirjanian said. "It's been a challenge but we are finally ready to launch."
Do you have a story that needs to be told? My DMs are open on Twitter @racheluranga. You can also email me.
From Your Site Articles
- artificial-intelligence - dot.LA ›
- Moxie the Robot Helps Children With Autism Through AI - dot.LA ›
- Moxie, Embedded's New Robot, Aims To Teach Kids Emotions - dot.LA ›
- Moxie, Embedded's New Robot, Aims To Teach Kids Emotions - dot.LA ›
- dot.LA Strategy Session: The Rise of Robotics - dot.LA ›
- How Curative Inc. Plans to Test the U.S. for Coronavirus - dot.LA ›
- How Curative Inc. Plans to Test the U.S. for Coronavirus - dot.LA ›
- Behind Her Empire Podcast: AI Trailblazer Rana el Kaliouby On Defying Expectations ›
- OK Play Says It's a Kids App Parents Won't Feel Guilty About - dot.LA ›
- Capsida Biotherapeutics Raises $140M for Its Gene Therapies - dot.LA ›
- Capsida Biotherapeutics Raises $140M for Its Gene Therapies - dot.LA ›
- Auticon Raises $4M to Grow Tech Jobs for Autistic Adults - dot.LA ›
- Graze Unveils an Autonomous Electric Lawn Mower - dot.LA ›
- How the CHLA Is Using Robots To Monitor Babies - dot.LA ›
Related Articles Around the Web
Read moreShow less
embodiedirobotcalibrate venturesroboticsmoxiejazz venturesrobotics and autonomous systems centerautismpixaridealabjplbill grossevolution roboticsartificial intelligenceairobokindsoftbank robotics
Rachel Uranga
Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.
https://twitter.com/racheluranga
rachel@dot.la
RELATEDTRENDING
LA TECH JOBS